Articles of the Month
Videos
Articles
Asthma Remission From Childhood to Young Adulthood–A Population-Based Cohort Study
L.Broströ, A.Bergströ, A.Merritt, et al.Allergy. First published:06 September 2026
Nasal Epithelial Immune Signatures Are Associated With Age-Dependent Asthma Trajectories in Early Life
C.A.Jakwerth, S.Illi, H.Charles, et al.Allergy. First published:06 September 2026
Pre-Seasonal Treatment With Recombinant Carrier-Based Birch Vaccine Improves Birch Pollen Allergy
M.R.Khaitov, M.G.Byazrova, E.V.Smolnikov, et al.Allergy. First published:04 September 2026
Tape Strip Transcriptomics Reveal Nemolizumab Effects on Pruritus, Hyperplasia, Inflammation, and Extracellular Matrix Markers in Patients With Moderate-to-Severe Atopic Dermatitis
D.Liu, E.D.Duca, N.Delaleu, et al.Allergy. First published:04 September 2026
Local Delivery of a Bio-Engineered IL-37 Fc-Fusion Ameliorates Experimental Allergic Asthma in Mice
L.P.Lunding, M.F.Nold, C.A.Nold-Petry, et al.Allergy. First published:03 September 2026
Classification of Seasonal Allergic Rhinitis Patients by Prospective Patient-Recorded Symptoms: The @IT.2020 Project
S.Dramburg, C.J.H.Toro, U.Grittner, et al.Allergy. First published:02 September 2026
Failed Mucosal Allostasis Distinguishes Murine IgG- From IgE-Mediated Recurrent Severe Anaphylaxis
A.Simsek, M.A.Kizmaz, T.Bozkurt, et al.Allergy. First published:01 September 2026
Impaired Clearance of Neutrophil Extracellular Traps in Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis
M.Kinoshita, Y.Ogawa, N.Hama, et al.Allergy. First published:31 August 2026
T Cell-Intrinsic NEIL2 Restrains Th2 Allergic Inflammation by Regulating Chromatin Accessibility
K.Hosoki, A.Sur, A.Govindhan, et al.Allergy. First published:31 August 2026
EAACI Spring Meeting 2026: Prevention as Treatment—A New Paradigm
M.J.Torres, M.A.Marković, A.Gelincik, et al.Allergy. First published:31 August 2026
The External Exposome and Food Allergy: How Environmental Exposures Shape Disease Risk
J.M.Smeekens, H.A.Brough, K.M.Järvinen, et al.Allergy. First published:31 August 2026
Targeting Airway Remodeling in Severe Asthma: Is There a Window of Opportunity for Biologic Therapy Predicting Effects Using Causal Artificial Intelligence?
S.Gangemi, S.Manti, J.C.Virchow, et al.Allergy. First published:27 August 2026
Pathways of Epithelial Barrier Breakdown and Remodeling in Esophageal Organoids by Commonly Used Surfactants
O.Ardicli, D.Yazici, H.Babayev, et al.Allergy. First published:27 August 2026
Need to Assess On-Demand Versus Continuous Treatment in Allergic Rhinitis in ARIA-EAACI Guidelines
J.Bousquet, B.Sousa-Pinto, M.J.Torres, et al.Allergy. First published:27 August 2026
Human IgE Antibodies Recognize the Vicilin and Alpha-Hairpinin Domains of Peanut Allergen Ara h 1
T.M.Cosey, G.O.Leighton, E.R.D.Diavoukana, et al.Allergy. First published:27 August 2026
Revisiting Platelet-Activating Factor in Asthma: An Exploratory Metabolomics Analysis of PAF C-18:1 and Type 2 Inflammation
N.Kang, Y.J.Pyung, D.K.Kim, et al.Allergy. First published:26 August 2026
Mepolizumab Modifies Blood Eosinophil Proteome and Transcriptome in Severe Eosinophilic Asthma
P. Miguéns-Suárez, S. Vázquez-Mera, L. Martelo-Vidal, et al.Allergy. First published:26 August 2026
Initial OX40–OX40L Signaling Promotes a Skin-Resident Memory T-Cell Reservoir in Atopic Dermatitis
T.Komatsu-Fujii, R.Asahina, T.Hasegawa, et al.Allergy. First published:25 August 2026
Epithelial AhR–NKX3-1–Senescence Axis Drives Barrier Function and Inflammation in Allergic Rhinitis
X.Yuan, Y.Zeng, S.Xie, et al.Allergy. First published:24 August 2026
From Risks to Protection—Natural Strategy to Prevent Allergy and Support Public Health
T.Haahtela, J.I.Halonen, H.Haveri, et al.Allergy. First published:23 August 2026
Placental Epigenetic Alterations and IL-10 Dysregulation Drive Early Persistent Food Allergy
E.J.Choi, S.H.Lee, S.H.Lee, et al.Allergy. First published:19 August 2026
Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non-Irritative Concentrations
A.Barbaud, L.H.Garvey, E.Phillips, et al.Allergy. First published:19 August 2026
Factors for Success and Failure of Allergen Immunotherapy (AIT) Trial Design in the Light of Evidence-Based Medicine: Current Aspects 2026
R.Wijk, V.Mahler, M.Albrecht, et al.Allergy. First published:18 August 2026
Corrigendum to “Epithelium-Derived Cystatin SN Inhibits House Dust Mite Protease Activity in Allergic Asthma”
Allergy. First published:18 August 2026
Nomenclature on Immune-Mediated Drug Reactions: An EAACI Position Paper
M.J.Torres, C.Mayorga, E.J.Phillips, et al.Allergy. First published:17 August 2026
Gut Microbiota Signatures Reflect Particulate Matter 2.5-Exacerbated Asthma in a Murine Model
T.Chen, C.C.K.Chou, B.Chiang.Allergy. First published:15 August 2026
Pathogenic Airway Bacteria and Local Immune Responses During Early-Life Asthma-Like Episodes
M.B.Svendsen, T.Sultan, A.Kjellberg, et al.Allergy. First published:15 August 2026
Parental and Healthcare Professional Experiences of Food Allergen Introduction During Complementary Feeding: A Behavioural Theory–Informed Systematic Review
K.Wright, A.Dennis, L.V.Marino, et al.Allergy. First published:14 August 2026
How to Train Your Chatbot: Information-Theoretic Foundations of Diagnostic Questioning in Inborn Errors of Immunity
S.O.L.Reyes, E.V.Echeverri, J.C.B.Ogando, et al.Allergy. First published:14 August 2026
Biomarkers Predicting Sustained Unresponsiveness After Oral Immunotherapy in the OPIA Trial
D.Ni, G.Pinget, B.Santner-Nanan, et al.Allergy. First published:14 August 2026
An Algorithm for the Diagnosis and Treatment of Allergic Contact Dermatitis (ACD)
J.D.Johansen, W.Uter, I.R.White, et al.Allergy. First published:13 August 2026
Hazelnut and Walnut Vicilins in Tree Nut Allergy: Co-Sensitization Patterns and Clinical Severity Associations
D.Villalta, G.Marcassa, G.Cusa, et al.Allergy. First published:12 August 2026
Influence of Environmental Pollution on Basophil Reactivity to Birch Pollen Allergens in Atopic and Non-Atopic Subjects
M.Czarnobilska, M.Bulanda, E.Czarnobilska, et al.Allergy. First published:11 August 2026
Expanding the Utility of Gold Nanocluster “Allergolds” to Peanut Allergen Ara h 2
G.O.Leighton, V.Martinez-Macias, E.R.D.Diavoukana, et al.Allergy. First published:10 August 2026
Citations: 342
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 147
EAACI guidelines: Anaphylaxis (2021 update)
Muraro A, Worm M, Alviani C, et al. Allergy. 2022; 77: 357–377
Citations: 118
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Maurer M, Magerl M, Betschel S, et al. Allergy. 2022; 77: 1961–1990
Citations: 118
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 114
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, et al. Allergy. 2022; 77: 1418–1449
Citations: 105
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 92
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., et al. Allergy. 2021; 76: 3307-3313
Citations: 90
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 88/h5>
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji MH, Valenta R, Jardetzky T, et al. Allergy. 2021; 76: 3627–3641
Citations: 82
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 81
Advances and highlights in allergic rhinitis
Zhang Y, Lan F, Zhang L. Allergy. 2021; 76: 3383–3389
Citations: 79
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 76
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 74
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Citations: 73
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Allergy. 2022; 77: 812–826
Citations: 70
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 69
Advances and highlights in biomarkers of allergic diseases
Ogulur I, Pat Y, Ardicli O, et al. Allergy. 2021; 76: 3659–3686
Citations: 69
Regulatory B cells, A to Z
Jansen, K., Cevhertas, L., Ma, S., Satitsuksanoa, P., Akdis, M. and van de Veen, W.
Citations: 62
Advances and highlights in asthma in 2021
Agache I, Eguiluz-Gracia I, Cojanu C, et al. Allergy. 2021; 76: 3390–3407
Citations: 62
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Citations: 61
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 2022; 77: 83-99
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Junior Members Corner
Dear Juniors,
EAACI Congress 2026 in Istanbul once again provided an outstanding opportunity for Junior Members to engage with the latest advances in allergy and clinical immunology while connecting with colleagues from across Europe and beyond. Bringing together clinicians, scientists and healthcare professionals from a wide range of disciplines, the congress fostered an inspiring environment for scientific exchange, collaboration and professional development.
For many Junior Members, the congress represented far more than attending lectures. It offered the opportunity to present research, discuss new ideas with internationally recognised experts, receive valuable feedback and build collaborations with peers from different institutions and countries. Dedicated sessions organised by the Junior Member Assembly (JMA) encouraged lively discussions on emerging topics across the specialty, providing an interactive platform for learning, exchanging experiences and showcasing the high-quality research being conducted by Junior Members.
Alongside the scientific programme, the JMA supported a range of educational and networking initiatives designed to promote the professional development of early-career members. Activities such as the EAACI Allergy College, the Clinical Research Challenge and the Junior Members Mentorship Programme created opportunities to strengthen mentoring relationships, develop new skills and establish international connections that often continue well beyond the congress itself. Together, these initiatives reflect EAACI’s continued commitment to supporting the next generation of allergy and clinical immunology professionals.
Perhaps the greatest strength of the EAACI Congress is the sense of community it creates. Whether attending for the first time or returning as experienced participants, Junior Members have the opportunity to become part of a collaborative international network united by a shared passion for research, education and improving patient care. We look forward to welcoming even more Junior Members to future EAACI meetings and encourage you to make the most of the many opportunities the JMA and the wider Academy provide throughout the year.
Best regards,
The Junior Member Assembly
EAACI Patients Organisation Committee Corner
HIGHLIGHTS FROM PAAM 2025
A group of ten Patient Organisations Committee (POC) members gathered at this wonderful venue in Palau de Congressos de Palma, Mallorca for 2025 Pediatric Allergy and Asthma Focused Meeting. Many had speaker slots giving lived experience perspectives of having children living with allergy and risk of anaphylaxis. So the EAACI PAAM Congress theme of ‘Inspiring insights for every family’ really resonated with us.
As POC, we are with EAACI to help where we can and it brings the science to a person experience, centred level. We had members a wide range of participants from Chile, USA, Turkey, UK, Sweden, Switzerland, France, Italy, Greece and Spain as POC has 36 POC members in 24 countries.
Our Chair, Ozlem Ceylan, gave an overview at the Opening Ceremony on why EAACI awareness campaigns matter, from awareness to action, so patients can feel heard and patient organisations can help lobby for policy change in their country.
POC participated in the Student Awareness Day that was set to educate 40 students aged 14-16 about allergic diseases and emergency response, with the local organising committee’s support.
One of our POC members, Esther Esteban Arroyo opened “The sister society session” with SEICAP and introduced their patient organisation, AEPNAA and their activities in Spain.
Mikaela Odemyr from Swedish Asthma and Allergy Association joined the Anaphylaxis session with a heartfelt talk, “When My Child Had Anaphylaxis: Expectations vs. Reality”. Fallon Schultz from IFPIES USA, gave a wonderful talk on parents’ perspective of dealing with a child’s FPIES journey and introduced their resources to support caregivers. On the last day of PAAM, Maria Zioga from Greece, gave a great talk, “From panic to preparedness: Building trust and resilience in food allergy care” and highlighted the importance of safety for food allergic children.
GA Gallery
<---
